MENU

APLS Apellis Pharmaceuticals Chart, History Price & Graph

a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases

A.I.Advisor
published price charts
Last 5 trading days

Apellis Pharmaceuticals, Inc. (APLS) Price Chart Analysis: Trend, Key Levels, and Technical Signals

Key Takeaways

  • APLS exhibits a strong uptrend, trading above key moving averages including the 50-day simple MA at 40.77 and 200-day at 27.49.
  • RSI(14) at 65.8 signals bullish momentum, approaching overbought territory.
  • MACD(12,26) shows a buy signal at 0.03, with ADX(14) at 54.65 confirming strong trend strength.
  • Near-term support cluster around 40.80-40.82, with resistance at 40.87-40.94; recent 52-week high at 40.90.
  • Overall technical summary indicates Strong Buy across moving averages and indicators.

Trend Analysis

Apellis Pharmaceuticals, Inc. (APLS) has established a robust uptrend, recently reaching a 52-week high near 40.90. The stock trades well above its longer-term moving averages, reflecting sustained bullish price action over the past quarter. This positioning above the 20-day, 50-day, and 200-day moving averages underscores a healthy technical posture, with the price consolidating near recent highs after a sharp rally.

Moving Averages

The moving averages present a predominantly bullish alignment for APLS. Shorter-term simple and exponential MAs at 5-day and 10-day levels hover around 40.86, showing minor sell signals amid tight consolidation. However, the 20-day MAs (40.85 simple, 40.84 exponential) and longer ones—50-day at 40.77 simple/39.65 exponential, 100-day at 36.44/36.34, and 200-day at 27.49/31.27—all indicate buy signals. This golden cross-like structure, with shorter MAs above longer ones, supports the prevailing uptrend.

Momentum Indicators

Momentum favors bulls in APLS, with RSI(14) at 65.8 in buy territory, suggesting building strength without extreme overbought conditions yet. MACD(12,26) at 0.03 delivers a buy signal, complemented by a strong ADX(14) reading of 54.65, indicating a powerful directional trend. Stochastic RSI(14) at 4.51 flags oversold on a short-term basis, potentially setting up for a rebound, while other oscillators like Williams %R and CCI remain neutral amid low volatility (ATR(14) at 0.02).

Support and Resistance Levels

Key levels for APLS cluster tightly around the current price of 40.87. Pivot points outline support at S1 40.83, S2 40.83, S3 40.82, with resistance at R1 40.85, R2 40.87, R3 40.87. Barchart analysis highlights blue support zones at 40.82 (1st support, 1 std dev) and 40.80 (2nd/3rd support), while red resistance bands span 40.87-40.94, including the recent high and MA cross stalls. The 50-day MA at 40.77 serves as dynamic support below.

Tickeron’s AI Daily Buy/Sell Signals

Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast arrays of market data, technical indicators, and historical price patterns for APLS and other stocks and ETFs. These signals arise from advanced algorithms that detect trends, momentum shifts, and recurring chart formations, providing traders with actionable insights. By evaluating factors like moving average crossovers, RSI divergences, and volume confirmations, the AI identifies potential buy or sell opportunities to pinpoint entry/exit points and validate ongoing trends. Popular among day traders and swing traders, these signals enhance decision-making without emotional bias. Explore the AI Daily Buy/Sell Signals to integrate AI-driven analysis into your APLS strategy.

Technical Outlook and Key Levels to Watch

Traders monitoring APLS will focus on whether the stock holds above the 40.80-40.82 support zone and 50-day MA at 40.77 amid any pullbacks. A sustained move above 40.90-40.94 resistance could signal further upside continuation in the uptrend. Watch RSI for potential overbought readings above 70 and MACD for histogram expansion or divergence. ADX strength suggests monitoring for trend persistence, with volume spikes as confirmation of breakouts or breakdowns from the current tight range.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

View a ticker or compare two or three
Interact to see
Advertisement
Apellis Pharmaceuticals, Inc. (APLS) Price Chart Analysis: Trend, Key Levels, and Technical Signals